Vaxxinity, Inc.

OTCPK:VAXX Stock Report

Market Cap: US$659.1k

Vaxxinity Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mei Hu

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage22.6%
CEO tenure11yrs
CEO ownership4.4%
Management average tenureless than a year
Board average tenure3.4yrs

Recent management updates

Recent updates

A Look At The Intrinsic Value Of Vaxxinity, Inc. (NASDAQ:VAXX)

Jan 08
A Look At The Intrinsic Value Of Vaxxinity, Inc. (NASDAQ:VAXX)

Vaxxinity initiates rolling submission for its COVID-19 shot with UK's drug regulator

Sep 12

CEO Compensation Analysis

How has Mei Hu's remuneration changed compared to Vaxxinity's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$308k

-US$57m

Sep 30 2023n/an/a

-US$66m

Jun 30 2023n/an/a

-US$72m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$532kUS$400k

-US$75m

Sep 30 2022n/an/a

-US$103m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

-US$123m

Dec 31 2021US$13mUS$400k

-US$137m

Sep 30 2021n/an/a

-US$102m

Jun 30 2021n/an/a

-US$88m

Mar 31 2021n/an/a

-US$68m

Dec 31 2020US$348kUS$335k

-US$40m

Compensation vs Market: Mei's total compensation ($USD1.36M) is above average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Mei's compensation has increased whilst the company is unprofitable.

CEO

Mei Hu (41 yo)

11yrs

Tenure

US$1,360,331

Compensation

Ms. Mei Mei Hu, J.D., serves as Chief Executive Officer of Vaxxinity, Inc. and has been its President has been its Director since 2014 and served as its President until June 2022. She Co-Founded Vaxxinity,...

Leadership Team

NamePositionTenureCompensationOwnership
Louis Reese
Co-Founder & Executive Chairman of the Board10.3yrsUS$1.29m3.13%
$ 20.7k
Mei Hu
Co-Founderno dataUS$1.36m4.35%
$ 28.7k
Sumita Ray
Chief Legal1.3yrsUS$823.41kno data
Jason Pesile
Chief Accounting Officerless than a yearno datano data
Jean-Cosme Dodart
Chief Scientific Officerless than a yearno datano data
Mark Joinnides
Chief of Staffno datano datano data
Manal Morsy
Chief Regulatory Officerless than a yearno datano data

1.0yrs

Average Tenure

46yo

Average Age

Experienced Management: VAXX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Louis Reese
Co-Founder & Executive Chairman of the Board10.3yrsUS$1.29m3.13%
$ 20.7k
Mei Hu
Co-Founder11yrsUS$1.36m4.35%
$ 28.7k
George Hornig
Independent Director3yrsUS$264.15k0%
$ 0
Peter Diamandis
Non-Employee Independent Director3.8yrsUS$233.94k1.59%
$ 10.5k
Eric Reiman
Member of Scientific Advisory Boardno datano datano data
Jeffrey Cummings
Member of Scientific Advisory Boardno datano datano data
Stanley Plotkin
Member of Scientific Advisory Boardno datano datano data
Gabrielle Toledano
Independent Director1.9yrsUS$259.99k0%
$ 0
Richard Mohs
Member of Scientific Advisory Boardno datano datano data
Brad Boeve
Member of Scientific Advisory Boardno datano datano data
Nick Fox
Member of Scientific Advisory Boardno datano datano data
Landon Ogilvie
Lead Independent Director1.9yrsUS$270.62k0.026%
$ 170.8

3.4yrs

Average Tenure

60yo

Average Age

Experienced Board: VAXX's board of directors are considered experienced (3.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 09:03
End of Day Share Price 2025/01/03 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vaxxinity, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Geoffrey MeachamBofA Global Research
Roger SongJefferies LLC